Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01419639
Brief Title: Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

First Submitted : August 17, 2011
First Submitted that Met QC Criteria : August 17, 2011
First Posted : August 18, 2011 (Estimate)

Results First Submitted : July 8, 2015
Results First Submitted that Met QC Criteria : July 8, 2015
Results First Posted : August 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 20, 2017
Last Update Posted : July 18, 2017